window.pageData = {"stock":{"_id":3000000026674,"name":"长江医药健康精选混合型发起式证券投资基金","fundSecondLevel":"hybrid","stockType":"fund","areaCode":"cn","market":"a","status":"normal","stockCode":"026674","tickerId":26674,"shortName":"长江医药健康精选混合发起C","currency":"CNY","exchange":"jj","masterFundFlag":null,"indexFundFlag":null,"activeFundFlag":null,"etfFundFlag":null,"lofFundFlag":null,"pensionTargetFlag":null,"feederFundFlag":null,"classificationFlag":null,"closedEnd":null,"inceptionDate":"2026-01-22T16:00:00.000Z","pinyin":"cjyyjkjxhhxfqszqtzjj","fundCollectionId":4000051260000,"fundCollection":{"exchange":"jjgs","stockType":"fund_collection","stockCode":"51260000","tickerId":51260000,"name":"长江证券（上海）资产管理有限公司"},"managers":[{"name":"李嘉琪","stockType":"fund_manager","stockCode":"j101020728","exchange":"fm","tickerId":121017266730}],"hotMetrics":{"fpr":{"stockId":3000000026674,"type":"fpr","f_cagr_p_r_fs_ssc":9232,"f_cagr_p_r_fs_ssrp":0.963817571227386,"f_p_r_m1_ssc":9270,"f_p_r_m1_ssrp":0.7743014348904952,"f_p_r_m3_ssc":9128,"f_p_r_m3_ssrp":0.8044264270844746},"fp":{"stockId":3000000026674,"type":"fp","last_data_date":"2026-06-04T16:00:00.000Z","f_p_r_m1":-0.05370389718942625,"f_p_r_m3":-0.06358560794044643,"f_cagr_p_r_fs":-0.097638736674305},"f_nlacan":{"stockId":3000000026674,"type":"f_nlacan","f_nv_d":"2026-06-04T16:00:00.000Z","f_nv":0.9057,"f_nv_cr":-0.01703928803993926},"f_as":{"stockId":3000000026674,"type":"f_as","f_tas":1542.564,"f_tas_d":"2026-03-30T16:00:00.000Z"}},"masterSlaveFunds":[{"_id":3000000026673,"__csrcFundId":16412,"stockCode":"026673","masterFundShortName":"长江医药健康精选混合发起","fundSecondLevel":"hybrid","stockType":"fund","areaCode":"cn","market":"a","tickerId":26673,"currency":"CNY","masterFundFlag":1,"status":"normal","exchange":"jj","shortName":"长江医药健康精选混合发起(026673)","lastUpdated":"2026-05-01T05:17:47.376Z","name":"长江医药健康精选混合型发起式证券投资基金","pinyin":"cjyyjkjxhhxfqszqtzjj","fundCollectionId":4000051260000,"setUpAssetScale":10012599.24,"setUpDate":"2026-01-19T16:00:00.000Z","setUpShares":10012599.24,"inceptionDate":"2026-01-22T16:00:00.000Z","followedNum":4}],"shareholdings":[{"date":"2026-03-30T16:00:00.000Z","declarationDate":"2026-04-21T16:00:00.000Z","fundId":3000000026673,"stockId":1000000000009926,"holdings":4000,"marketCap":459840,"netValueRatio":0.0475,"quarterlyChange":0.1522123893805305,"stock":{"stockType":"company","exchange":"hk","stockCode":"09926","tickerId":9926,"name":"康方生物"}},{"date":"2026-03-30T16:00:00.000Z","declarationDate":"2026-04-21T16:00:00.000Z","fundId":3000000026673,"stockId":1000000000006990,"holdings":1000,"marketCap":406157,"netValueRatio":0.0419,"quarterlyChange":0.17287098419173907,"stock":{"exchange":"hk","stockType":"company","stockCode":"06990","tickerId":6990,"name":"科伦博泰生物"}},{"date":"2026-03-30T16:00:00.000Z","declarationDate":"2026-04-21T16:00:00.000Z","fundId":3000000026673,"stockId":688513,"holdings":6000,"marketCap":386340,"netValueRatio":0.0399,"quarterlyChange":0.046141348497156676,"stock":{"stockCode":"688513","tickerId":688513,"exchange":"sh","stockType":"company","name":"苑东生物"}},{"date":"2026-03-30T16:00:00.000Z","declarationDate":"2026-04-21T16:00:00.000Z","fundId":3000000026673,"stockId":688331,"holdings":3000,"marketCap":386310,"netValueRatio":0.0399,"quarterlyChange":0.6553541586322154,"stock":{"name":"荣昌生物","exchange":"sh","stockType":"company","stockCode":"688331","tickerId":688331}},{"date":"2026-03-30T16:00:00.000Z","declarationDate":"2026-04-21T16:00:00.000Z","fundId":3000000026673,"stockId":603259,"holdings":3700,"marketCap":362970,"netValueRatio":0.0375,"quarterlyChange":0.08230361871138547,"stock":{"stockCode":"603259","exchange":"sh","stockType":"company","tickerId":603259,"name":"药明康德"}},{"date":"2026-03-30T16:00:00.000Z","declarationDate":"2026-04-21T16:00:00.000Z","fundId":3000000026673,"stockId":300683,"holdings":8000,"marketCap":346880,"netValueRatio":0.0358,"quarterlyChange":0.563649477100612,"stock":{"stockCode":"300683","exchange":"sz","stockType":"company","tickerId":300683,"name":"海特生物"}},{"date":"2026-03-30T16:00:00.000Z","declarationDate":"2026-04-21T16:00:00.000Z","fundId":3000000026673,"stockId":688192,"holdings":6000,"marketCap":325140,"netValueRatio":0.0336,"quarterlyChange":-0.059201388888888706,"stock":{"stockCode":"688192","tickerId":688192,"exchange":"sh","stockType":"company","name":"迪哲医药"}},{"date":"2026-03-30T16:00:00.000Z","declarationDate":"2026-04-21T16:00:00.000Z","fundId":3000000026673,"stockId":1000000000001530,"holdings":15000,"marketCap":299849,"netValueRatio":0.031,"quarterlyChange":-0.06368899917286963,"stock":{"stockCode":"01530","exchange":"hk","stockType":"company","tickerId":1530,"name":"三生制药"}},{"date":"2026-03-30T16:00:00.000Z","declarationDate":"2026-04-21T16:00:00.000Z","fundId":3000000026673,"stockId":1000000000001801,"holdings":4000,"marketCap":299849,"netValueRatio":0.031,"quarterlyChange":0.11344262295081897,"stock":{"stockCode":"01801","exchange":"hk","stockType":"company","tickerId":1801,"name":"信达生物"}},{"date":"2026-03-30T16:00:00.000Z","declarationDate":"2026-04-21T16:00:00.000Z","fundId":3000000026673,"stockId":2821,"holdings":2400,"marketCap":265848,"netValueRatio":0.0274,"quarterlyChange":0.19197245238351623,"stock":{"stockCode":"002821","exchange":"sz","stockType":"company","tickerId":2821,"name":"凯莱英"}}]},"list":[{"_id":"69e8ecca1398d79843fea21c","date":"2026-03-30T16:00:00.000Z","declarationDate":"2026-04-21T16:00:00.000Z","stockId":3000000026673,"sao":"回顾一季度，医药板块整体呈现震荡态势。新年伊始，全球科技领域迎来新一轮创新突破，人工智能（AI）与脑机接口两大前沿方向为医药板块注入活力，相关标的表现较好。一季度后半段，全球地缘政治局势出现局部紧张，部分地区爆发军事冲突，对宏观经济和市场情绪产生阶段性冲击。在人口老龄化日益加剧的今天，医药行业刚需属性凸显，在动荡环境中逐渐表现出一定的韧性。纵观医药多个细分领域，创新药仍是产业趋势最积极、成长性最强的主线方向。政策端，2026年政府工作报告第一次将生物医药列为新兴支柱产业，与各类政策协同，全方位支持创新药高质量发展。出海端，新闻联播报道1-3月创新药对外授权交易总金额600亿美金，已经接近去年的一半，中国创新药的全球竞争力持续加强。业绩端，多家龙头公司进入扭亏为盈的阶段，行业其他公司也逐步进入商业化验证的过程中。本基金成立之际，创新药板块已经在去年涨幅显著的情况下进行了部分调整，故而一季度建仓初期本基金重点布局具备全球竞争力的A股、港股创新药及创新药产业链资产，兼顾医疗AI等优质标的，把握板块复苏机遇，并通过合理的仓位控制适度规避宏观环境带来的风险。展望后市，创新药板块预计会在行业学术大会（临床数据披露）、重磅出海授权交易、前沿技术突破等多重因素推动下持续迎来发展机遇。我们将持续跟踪企业国际化进展与技术突破，在估值与成长性中寻找平衡，筛选研发投入足、管线新颖、国际化能力强的标杆企业，进一步优化持仓结构，为投资者把握产业升级带来的机遇。","lastUpdated":"2026-04-22T15:44:10.616Z","fund":{"_id":3000000026673,"__csrcFundId":16412,"stockCode":"026673","masterFundShortName":"长江医药健康精选混合发起","fundSecondLevel":"hybrid","stockType":"fund","areaCode":"cn","market":"a","tickerId":26673,"currency":"CNY","masterFundFlag":1,"status":"normal","exchange":"jj","shortName":"长江医药健康精选混合发起(026673)","lastUpdated":"2026-05-01T05:17:47.376Z","name":"长江医药健康精选混合型发起式证券投资基金","pinyin":"cjyyjkjxhhxfqszqtzjj","fundCollectionId":4000051260000,"setUpAssetScale":10012599.24,"setUpDate":"2026-01-19T16:00:00.000Z","setUpShares":10012599.24,"inceptionDate":"2026-01-22T16:00:00.000Z","followedNum":4,"managers":[{"stockCode":"j101020728","stockType":"fund_manager","exchange":"fm","tickerId":121017266730,"name":"李嘉琪"}]},"announcement":{"linkText":"长江医药健康精选混合型发起式证券投资基金2026年第一季度报告","linkUrl":"http://eid.csrc.gov.cn/fund/disclose/instance_show_pdf_id.do?instanceid=1468835","linkType":"PDF","source":"csrc_pdf"}}]}